Genomic complexity and AKT dependence in serous ovarian cancer.

@article{Hanrahan2012GenomicCA,
  title={Genomic complexity and AKT dependence in serous ovarian cancer.},
  author={Aphrothiti J. Hanrahan and Nikolaus Schultz and Maggie L Westfal and Rita A. Sakr and Dilip D. Giri and Stefano Scarperi and M. Janakiraman and Narciso Olvera and Ellen V Stevens and Qing-Bai She and Carol A. Aghajanian and Tari A. King and Elisa de Stanchina and David R. Spriggs and Adriana Heguy and Barry S. Taylor and Chris Sander and Neal Rosen and Douglas A. Levine and David B. Solit},
  journal={Cancer discovery},
  year={2012},
  volume={2 1},
  pages={56-67}
}
UNLABELLED Effective oncoprotein-targeted therapies have not yet been developed for ovarian cancer. To explore the role of PI3 kinase/AKT signaling in this disease, we performed a genetic and functional analysis of ovarian cancer cell lines and tumors. PI3K pathway alterations were common in both, but the spectrum of mutational changes differed. Genetic activation of the pathway was necessary, but not sufficient, to confer sensitivity to selective inhibition of AKT and cells with RAS pathway… CONTINUE READING
49 Citations
28 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Genomic complexity and AKT dependence in serous ovarian cancer

  • AJ Hanrahan, N Schultz, ML Westfal, RA Sakr, DD Giri, S Scarperi
  • Cancer Discovery
  • 2012

AKT 1 ( E 17 K ) in human solid tumours

  • FE Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo
  • Oncogene
  • 2008

Similar Papers

Loading similar papers…